CCL2 and neoplasm: Tumor-derived CCL2 has also been shown to act directly on the endothelium to promote its activation, resulting in enhanced monocyte recruitment, dephosphorylation of VE-Cadherin, reduced tight junction integrity, and a consequential increase in tumor cell transmigration (95).